Park Ha Biological Technology Co., Ltd. Cash Flow Conversion Efficiency
Park Ha Biological Technology Co., Ltd. cash flow conversion efficiency. Based on the latest financial reports, Park Ha Biological Technology Co., Ltd. (PHH) has a cash flow conversion efficiency ratio of -0.112x as of June 2018. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-55.00 Million) by net assets ($489.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Park Ha Biological Technology Co., Ltd. (1993–2024)
Cash flow conversion efficiency of Park Ha Biological Technology Co., Ltd. from 1993 to 2024. This chart illustrates how Park Ha Biological Technology Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View PHH stock price for real-time trading data and today's change.
Park Ha Biological Technology Co., Ltd. Cash Flow Conversion Ratio Explained
Park Ha Biological Technology Co., Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Park Ha Biological Technology Co., Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Park Ha Biological Technology Co., Ltd. ranked by their cash flow conversion efficiency. Also see Park Ha Biological Technology Co., Ltd. market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OXE Marine AB
ST:OXE
|
-0.326x |
|
Tong Hua Holding Public Company Limited
BK:TH
|
-0.006x |
|
Armlogi Holding Corp. Common Stock
NASDAQ:BTOC
|
-0.157x |
|
Minnova Corp
V:MCI
|
0.162x |
|
MONY Group plc
LSE:MONY
|
0.279x |
|
Moleculin Biotech Inc
NASDAQ:MBRX
|
-0.358x |
|
PNC Technologies co. Ltd
KQ:237750
|
0.017x |
|
Telefast Indonesia
JK:TFAS
|
0.023x |
Annual Cash Flow Conversion Efficiency for Park Ha Biological Technology Co., Ltd. (1993–2024)
The table below shows the annual cash flow conversion efficiency of Park Ha Biological Technology Co., Ltd. from 1993 to 2024. Review how much free cash does Park Ha Biological Technology Co., Ltd. generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.51 Million | $960.47K | 0.638x | +410.27% |
| 2023-12-31 | $1.01 Million | $126.54K | 0.125x | -98.70% |
| 2022-12-31 | $150.28K | $1.44 Million | 9.598x | +1014.62% |
| 2021-12-31 | $-578.18K | $-497.86K | 0.861x | +372.88% |
| 2017-12-31 | $1.66 Billion | $303.00 Million | 0.182x | +339.76% |
| 2016-12-31 | $1.76 Billion | $73.00 Million | 0.041x | -29.85% |
| 2015-12-31 | $2.05 Billion | $121.00 Million | 0.059x | +942.98% |
| 2014-12-31 | $1.57 Billion | $-11.00 Million | -0.007x | -100.44% |
| 2013-12-31 | $1.69 Billion | $2.71 Billion | 1.603x | +21.72% |
| 2012-12-31 | $1.56 Billion | $2.06 Billion | 1.317x | -30.94% |
| 2011-12-31 | $1.46 Billion | $2.79 Billion | 1.907x | +279.11% |
| 2010-12-31 | $1.58 Billion | $-1.68 Billion | -1.065x | -224.80% |
| 2009-12-31 | $1.50 Billion | $1.28 Billion | 0.853x | -42.86% |
| 2008-12-31 | $1.27 Billion | $1.89 Billion | 1.493x | -12.49% |
| 2007-12-31 | $1.56 Billion | $2.66 Billion | 1.706x | +252.60% |
| 2006-12-31 | $1.55 Billion | $748.00 Million | 0.484x | +70.32% |
| 2005-12-31 | $3.22 Billion | $915.00 Million | 0.284x | -53.01% |
| 2004-12-31 | $4.15 Billion | $2.51 Billion | 0.605x | -35.09% |
| 2003-12-31 | $4.12 Billion | $3.84 Billion | 0.931x | +68.51% |
| 2002-12-31 | $2.87 Billion | $1.59 Billion | 0.553x | -33.14% |
| 2001-12-31 | $1.78 Billion | $1.47 Billion | 0.827x | +103.14% |
| 2000-12-31 | $1.87 Billion | $761.00 Million | 0.407x | -50.36% |
| 1999-12-31 | $1.63 Billion | $1.34 Billion | 0.820x | +65.35% |
| 1998-12-31 | $1.74 Billion | $861.70 Million | 0.496x | -18.23% |
| 1997-12-31 | $1.51 Billion | $918.24 Million | 0.606x | +259.22% |
| 1995-12-31 | $4.58 Billion | $772.68 Million | 0.169x | -22.56% |
| 1994-12-31 | $4.18 Billion | $910.92 Million | 0.218x | -80.58% |
| 1993-12-31 | $498.31 Million | $559.19 Million | 1.122x | -- |
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells produ… Read more